Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 510679, 9 pages
http://dx.doi.org/10.1155/2015/510679
Research Article

Synthesis and Validation of a Hydroxypyrone-Based, Potent, and Specific Matrix Metalloproteinase-12 Inhibitor with Anti-Inflammatory Activity In Vitro and In Vivo

1Laboratory of Neuroplasticity and Neuroproteomics, KU Leuven, Naamsestraat 59, 3000 Leuven, Belgium
2Inflammation Research Center, VIB, Technologiepark 927, 9052 Ghent, Belgium
3Department of Biomedical Molecular Biology, Ghent University, Technologiepark 927, 9052 Ghent, Belgium
4Molecular Design and Synthesis, KU Leuven, Celestijnenlaan 200f, 3001 Leuven, Belgium
5Organic and Bio-Polymer Chemistry, UHasselt, Agoralaan Building D, 3590 Diepenbeek, Belgium
6Laboratory of Neural Circuit Development and Regeneration, KU Leuven, Naamsestraat 61, 3000 Leuven, Belgium

Received 18 May 2015; Accepted 2 July 2015

Academic Editor: Denis Girard

Copyright © 2015 J. Aerts et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. D. Sternlicht and Z. Werb, “How matrix metalloproteinases regulate cell behavior,” Annual Review of Cell and Developmental Biology, vol. 17, pp. 463–516, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. I. M. Ethell and D. W. Ethell, “Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets,” Journal of Neuroscience Research, vol. 85, no. 13, pp. 2813–2823, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Cauwe and G. Opdenakker, “Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases,” Critical Reviews in Biochemistry and Molecular Biology, vol. 45, no. 5, pp. 351–423, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. R. E. Vandenbroucke and C. Libert, “Is there new hope for therapeutic matrix metalloproteinase inhibition?” Nature Reviews Drug Discovery, vol. 13, pp. 904–927, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. P. T. Elkington, J. A. Green, and J. S. Friedland, “Analysis of matrix metalloproteinase secretion by macrophages,” Methods in Molecular Biology, vol. 531, pp. 253–265, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. M. Lalu, J. Cena, R. Chowdhury, A. Lam, and R. Schulz, “Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction,” British Journal of Pharmacology, vol. 149, no. 1, pp. 31–42, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Dubois, S. Starckx, A. Pagenstecher, J. van den Oord, B. Arnold, and G. Opdenakker, “Gelatinase B deficiency protects against endotoxin shock,” European Journal of Immunology, vol. 32, no. 8, pp. 2163–2171, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. S. L. Tressel, N. C. Kaneider, S. Kasuda et al., “A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsis,” EMBO Molecular Medicine, vol. 3, no. 7, pp. 370–384, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. R. E. Vandenbroucke, E. Dejonckheere, P. Van Lint et al., “Matrix metalloprotease 8-dependent extracellular matrix cleavage at the blood-CSF barrier contributes to lethality during systemic inflammatory diseases,” Journal of Neuroscience, vol. 32, no. 29, pp. 9805–9816, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. S. R. Maitra, A. Jacob, M. Zhou, and P. Wang, “Modulation of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis,” International Journal of Clinical and Experimental Medicine, vol. 3, no. 3, pp. 180–185, 2010. View at Google Scholar · View at Scopus
  11. R. E. Vandenbroucke, L. Dejager, and C. Libert, “The first MMP in sepsis,” EMBO Molecular Medicine, vol. 3, no. 7, pp. 367–369, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. R. E. Vandenbroucke, E. Dejonckheere, F. Van Hauwermeiren et al., “Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF,” EMBO Molecular Medicine, vol. 5, no. 7, pp. 932–948, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. R. E. Vandenbroucke, I. Vanlaere, F. Van Hauwermeiren, E. Van Wonterghem, C. Wilson, and C. Libert, “Pro-inflammatory effects of matrix metalloproteinase 7 in acute inflammation,” Mucosal Immunology, vol. 7, no. 3, pp. 579–588, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Lauhio, J. Hästbacka, V. Pettilä et al., “Serum MMP-8, -9 and TIMP-1 in sepsis: High serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines,” Pharmacological Research, vol. 64, no. 6, pp. 590–594, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. P. D. Solan, K. E. Dunsmore, A. G. Denenberg, K. Odoms, B. Zingarelli, and H. R. Wong, “A novel role for matrix metalloproteinase-8 in sepsis,” Critical Care Medicine, vol. 40, no. 2, pp. 379–387, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. C. M. Overall and O. Kleifeld, “Towards third generation matrix metalloproteinase inhibitors for cancer therapy,” British Journal of Cancer, vol. 94, no. 7, pp. 941–946, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. D. T. Puerta, M. O. Griffin, J. A. Lewis et al., “Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivity,” Journal of Biological Inorganic Chemistry, vol. 11, no. 2, pp. 131–138, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. L. M. Coussens, B. Fingleton, and L. M. Matrisian, “Matrix metalloproteinase inhibitors and cancer: trials and tribulations,” Science, vol. 295, no. 5564, pp. 2387–2392, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. D. Liu, S. Piyamongkol, D. Y. Liu, H. H. Khodr, S. L. Lu, and R. C. Hider, “Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values,” Bioorganic and Medicinal Chemistry, vol. 9, no. 3, pp. 563–573, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. M. M. Finnegan, S. J. Rettig, and C. Orvig, “A neutral water-soluble aluminum complex of neurological interest,” Journal of the American Chemical Society, vol. 108, no. 16, pp. 5033–5035, 1986. View at Publisher · View at Google Scholar · View at Scopus
  21. D. T. Puerta, J. Mongan, B. L. Tran, J. A. McCammon, and S. M. Cohen, “Potent, selective pyrone-based inhibitors of stromelysin-1,” Journal of the American Chemical Society, vol. 127, no. 41, pp. 14148–14149, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. January 2015, http://www.alfa.com/en/catalog/L17450.
  23. J. Vandesompele, K. De Preter, F. Pattyn et al., “Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes,” Genome Biology, vol. 3, Article ID RESEARCH0034, 2002. View at Google Scholar
  24. L. Liu and K. Duff, “A technique for serial collection of cerebrospinal fluid from the cisterna magna in mouse,” Journal of Visualized Experiments, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. T. R. Menheniott, M. Charalambous, and A. Ward, “Derivation of primary choroid plexus epithelial cells from the mouse,” Methods in Molecular Biology, vol. 633, pp. 207–220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Szulcek, H. J. Bogaard, and G. P. V. N. Amerongen, “Electric cell-substrate impedance sensing for the quantification of endothelial proliferation, barrier function, and motility,” Journal of Visualized Experiments, no. 85, Article ID e51300, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. L. L. Johnson, A. G. Pavlovsky, A. R. Johnson et al., “A rationalization of the acidic pH dependence for stromelysin-1 (matrix metalloproteinase-3) catalysis and inhibition,” The Journal of Biological Chemistry, vol. 275, no. 15, pp. 11026–11033, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. H. I. Park, Y. Jin, D. R. Hurst et al., “The intermediate S1′ pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling,” The Journal of Biological Chemistry, vol. 278, no. 51, pp. 51646–51653, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Sonneville, F. Verdonk, C. Rauturier et al., “Understanding brain dysfunction in sepsis,” Annals of Intensive Care, vol. 3, article 15, 2013. View at Publisher · View at Google Scholar · View at Scopus